ReACT Phase II trial: a critical evaluation of the use of rindopepimut plus bevacizumab to treat EGFRvIII-positive recurrent glioblastoma.
| Image |  |
|---|---|
| Description | scientific article published on 15 December 2015 |
| Author/s |
author: Na Tosha Gatson |
| Publication date | December 15, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Access work | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |